-
Lilly grabs first-ever FDA nod for a sleep apnoea drug
22 Dec 2024 18:41 GMT
… ) can be used to treat moderate-to-severe OSA, … critical care at the FDA Centre for Drug Evaluation and Research … complications such as heart attack, glaucoma, diabetes, cancer, and cognitive … OSA symptoms and know that treatments are available, including new …
-
Glaucoma Treatment Market 2034: FDA Approval, Clinical Trials, Medication, Companies by DelveInsight
20 Dec 2024 21:00 GMT
… conditions. Treatment aims to lower IOP through medications, … sales of each drug.
Glaucoma Drugs Uptake helps in … develop novel therapies which will drive the Glaucoma treatment … markets in the upcoming years are Allergan, Sun Pharma …
-
A Randomized Pilot Study of Four Dosing Schemes of Sublingual Methazolamide in Glaucoma Patients
20 Dec 2024 18:16 GMT
… depending on the glaucoma medications they were using … received the intended treatment dosings as assigned … another tool for effectively treating glaucoma patients.
Abbreviations
IOP … Angle Glaucoma; CAIs, Carbonic Anhydrase Inhibitors; FDA, Food and Drug …
-
Berry Global Healthcare to Showcase New Packaging Innovations at Pharmapack 2025
20 Dec 2024 14:22 GMT
… its CDMO (Contract Development and Manufacturing Organisation) … PP) containers for pills and tablets that offer … treat a wide range of eye conditions such as Conjunctivitis and Glaucoma … pharmaceutical professionals with innovations in packaging and drug …
-
Top FDA stories of 2024: New technology, potentially contaminated eye drops
20 Dec 2024 15:28 GMT
… glaucoma, presbyopia, cataracts and ocular hypertension.” Read more. FDA … Ocuphire Pharma has received agreement from the FDA under … trial, a study of phentolamine ophthalmic solution for treatment … the FDA described both products as “unapproved new drugs” …
-
Glaucoma 360 offering cutting-edge innovations and networking opportunities
19 Dec 2024 22:22 GMT
… physician, researcher, inventor, and technology developer.” Michael Belkin, MD, MA, … Industry Panel Discussion: Glaucoma Devices and Pharmaceuticals
Reimagining Glaucoma Drugs and Drug Delivery
Break, … there. We even have the FDA present, which is an amazing …
-
Study validates long-term efficacy of MicroPulse TLT for glaucoma management
19 Dec 2024 22:22 GMT
Iridex Corp., a global leader in laser-based medical systems for glaucoma and retinal disease treatment, has announced the publication of a pivotal peer-reviewed study in Ophthalmology Therapy.
This research demonstrates the sustained safety and efficacy …
-
Sight Sciences Announces the Results of a Budget Impact Analysis for its TearCare® System for the Treatment of Meibomian Gland Disease (“MGD”) Showing Cost Savings Over Existing Reimbursed Treatment Options
19 Dec 2024 21:05 GMT
… technology company focused on developing and commercializing innovative, … commonly prescribed dry eye medications, including Restasis 0.05% … increased adoption of TearCare treatments for patients with … patients with open-angle glaucoma. Glaucoma is the world’ …
-
Sight Sciences Announces The Results Of A Budget Impact Analysis For Its Tearcare® System For The Treatment Of Meibomian Gland Disease (“MGD”) Showing Cost Savings Over Existing Reimbursed Treatment Options
19 Dec 2024 21:58 GMT
… technology company focused on developing and commercializing innovative, … commonly prescribed dry eye medications, including Restasis 0.05% … increased adoption of TearCare treatments for patients with … patients with open-angle glaucoma. Glaucoma is the world…
-
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
19 Dec 2024 13:00 GMT
… drug exclusivity (ODE) to Libervant® (diazepam) Buccal Film for the acute treatment … FDA’s Office of Orphan Products Development grants orphan designation status to drugs … narrow angle glaucoma.
What is … Product Information: Medication Guide and Instructions …